Emerging Pharmaceutical Exposures in the Life Sciences Sector

When things go wrong in the pharmaceutical sector, they tend to go very wrong. As recent Tylenol litigation shows, allegations can arise years after the initial development and sale of a pharmaceutical product, and companies …